1972 Porsche 914 Base 1.7l Fuel Injected on 2040-cars
Chicago, Illinois, United States
Body Type:U/K
Engine:1.7L 1679CC 103Cu. In. H4 GAS OHV Naturally Aspirated
Vehicle Title:Clear
Fuel Type:GAS
For Sale By:Private Seller
Number of Cylinders: 4
Make: Porsche
Model: 914
Trim: Base
Warranty: Vehicle does NOT have an existing warranty
Drive Type: U/K
Exterior Color: Yellow
Mileage: 100,000
Interior Color: Black
1972 914 porsche from california new tires fuel injected very rust free for more info call dennis 847 521 9442
Porsche 914 for Sale
Auto Services in Illinois
West Side Motors ★★★★★
Turi`s Auto Collision Center ★★★★★
Transmissions R US ★★★★★
The Autobarn Nissan ★★★★★
Tech Auto Svc ★★★★★
T Boe Inc ★★★★★
Auto blog
Porsche (finally) unleashes full, official details on 918 Spyder
Mon, 09 Sep 2013Porsche has finally let released all of the details on the 918 Spyder, the German brand's challenger to the McLaren P1 and Ferrari LaFerrari, after months of leading our poor, performance-loving hearts on. The covers were lifted at the Volkswagen Group night, an enormous precursor to the Frankfurt Motor Show, and include a massive, 11,000-word press release that's attached at the bottom of this page.
The 918 Spyder features a mid-mounted, dry-sump-lubricated, 4.6-liter V8 engine that generates 608 horsepower when left to its own devices. Combined with a trio of electric motors, which produce 286 hp, the total system horsepower for the 918 Spyder rests at 887 ponies. That's less than the McLaren P1 (903 hp) and the LaFerrari (949 hp), but the Porsche is also likely to be a bit cheaper, starting at $845,000, while the McLaren will be in the seven-figure range for certain, and it will more than likely be joined by the LaFezza.
The 918 Spyder counters with a 2.8-second jog to 62, a 7.7-second run to 124 and it will hit 186 in 22 seconds.
Porsche employees take pay cuts so they can build Mission E
Wed, Dec 30 2015Porsche's 13,000 workers in Zuffenhausen, Germany, agreed to work more and at adjusted wages to ensure that the factory can build the production version the Mission E electric performance sedan. Their sacrifices could save the German sports car maker several hundred million euros, according to Reuters. The Zuffenhausen site was possibly in danger of losing the Mission E because workers there receive higher wages than Porsche's other factories. The specific savings from these concessions reportedly include increasing the workweek by one hour to 35 hours and eliminating portions of pay increases between 2016 and 2025. Porsche didn't officially confirm the precise cuts, but a spokesperson told Reuters: "Employer and employees have jointly drawn up measures that have led to the decision of producing the Mission E model at Zuffenhausen." Porsche plans to invest about $768 million into the Zuffenhausen factory over the coming years. That money will help create over 1,000 new jobs and will build a new paint shop, assembly plant, and upgrade the engine factory to produce electric motors. The expansion will also allow the company to move all production of the Cayman and Boxster to Zuffenhausen by August 2016 rather than the current strategy of outsourcing some of the models' assembly to Osnabruck, Germany. The Mission E should enter production by 2020, and Porsche Executive Board Chairman Dr. Oliver Blume promises it to be the "most sophisticated model in this market segment." The concept at the 2015 Frankfurt Motor Show offered a glimpse at the next-gen technology by presenting a swoopy EV sport sedan with all-wheel drive and a total of 590 horsepower from two electric motors. Porsche claimed the concept could reach 62 miles per hour in just 3.5 seconds and go nearly 311 miles on the European testing cycle.
Porsche suspends ties with Maria Sharapova after drug test
Tue, Mar 8 2016Porsche has reportedly suspended ties with Maria Sharapova after the Russian tennis star failed a drug test. The German automaker stopped short of terminating its relationship with the athlete altogether as it awaits the results of a deeper investigation. The issue emerged at the Australian Open, where Sharapova reportedly tested positive for use of a drug called meldonium. Manufactured in Latvia and prescribed in many former Soviet Bloc countries, meldonium is used to treat heart conditions and improve cardiac circulation. It is not approved by the FDA for use in the United States, and the World Anti-Doping Agency added it to its list of prohibited substances at the start of this year. Sharapova admitted that she's been taking the medication for ten years now but that she did not keep up to date on the WADA's list. Since it is considered a prohibited substance, she's been excluded from participating in the Australian Open this year, and suspended from competition as of March 12. She was also scheduled to take part in the Porsche Grand Prix, a tennis event sponsored by the carmaker in Stuttgart next month which she will now apparently have to miss. One of the top-rated female tennis players in the world, Sharapova has served as a brand ambassador for Porsche since 2013. Other sponsors including TAG Heuer and Nike have also reportedly suspended their relationships with the athlete pending further investigation by the International Tennis Federation. Related Video: